Skip to main content
Adocia logo

Adocia — Investor Relations & Filings

Ticker · ADOC ISIN · FR0011184241 LEI · 969500ZL79KYH9PTYP78 PA Real estate activities
Open in API
Filings indexed 826 across all filing types
Latest filing 2020-12-21 Report Publication Anno…
Country FR France
Listing PA ADOC

About Adocia

https://www.adocia.com

Adocia is a clinical-stage biotechnology company that specializes in developing innovative treatments for metabolic diseases, with a primary focus on diabetes and obesity. The company's core expertise is the development of novel formulations of approved peptides, proteins, and metabolic hormones, such as insulin, to improve their therapeutic efficacy. Adocia leverages proprietary technology platforms to create a pipeline of specialty products. Its research also extends to novel cell therapy approaches, including an immunoprotective scaffold for cell delivery. The company's business model involves advancing its product candidates to clinical proof-of-concept before licensing them to partners for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is titled "Adocia announces its financial calendar for 2021" and lists future dates for the publication of financial statements (2020, Q1 2021, Mid-year, Q3 2021) and the Annual Shareholders' Meeting. This is not the actual financial report (10-K or IR), nor is it a transcript (CT) or an earnings release (ER). It is an announcement detailing *when* future reports and events will occur. According to Rule 2, if a document announces the publication of reports, it should be classified as a Report Publication Announcement (RPA). The document is short (5095 chars) and its primary function is to communicate the schedule of upcoming corporate information releases.
2020-12-21 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is a press release ("COMMUNIQUE DE PRESSE") dated December 21, 2020, announcing the company's financial calendar for the year 2021. It explicitly lists dates for the publication of annual results, Q1 revenue, the Annual General Meeting (Assemblée Générale 2021), half-year results, and Q3 revenue. This type of announcement, which details the schedule for future mandatory financial disclosures and shareholder meetings, is best classified as a Report Publication Announcement (RPA), as it announces *when* reports will be released, rather than being the report itself (like 10-K or ER). The document also mentions the upcoming publication of the Universal Registration Document (Document d'Enregistrement Universel) in Q2 2021, further supporting the classification as an announcement about future reporting events.
2020-12-21 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled 'Information relative au nombre d'actions et de droits de vote en date du 30 novembre 2020' and explicitly states it is published in compliance with the French Commercial Code (Code de Commerce) and AMF regulations (Article 223-16). It provides a table detailing the 'Nombre d'actions' (Number of shares) and 'Nombre de droits de vote' (Number of voting rights) as of a specific date (November 30, 2020). This type of periodic disclosure regarding the total number of shares and voting rights is a specific regulatory requirement, often related to major shareholding notifications or capital structure updates, but the core content is a formal declaration of share capital and voting power. This aligns most closely with 'Major Shareholding Notification' (MRQ) or a general regulatory filing (RNS). Since it is a formal, periodic declaration of the capital structure and voting rights based on regulatory articles, and not a general announcement of a report (RPA) or a director's trade (DIRS), MRQ is the most specific fit, as changes in total voting rights often trigger disclosure thresholds. However, given the options, this specific type of filing (total shares/votes disclosure) is often categorized under general regulatory announcements or share capital changes. Since it is a formal regulatory disclosure of the capital base, and not a change in ownership by an individual (MRQ), or a general share transaction (POS), it fits best as a specific regulatory disclosure. In many contexts, this is filed under the equivalent of a major shareholding notification or a general regulatory filing. Given the precise nature of reporting total shares and voting rights, MRQ (Major Shareholding Notification) is often the closest category for these periodic capital structure disclosures, even if it's the company reporting its own total, as it relates to the base for threshold crossings. If MRQ is interpreted strictly as notification *by* a major shareholder crossing a threshold, then RNS (Regulatory Filings) is the fallback. Since the document explicitly details the total voting rights base, which is crucial for threshold monitoring, MRQ is a strong candidate. Let's re-evaluate against the definitions. It is not a dividend (DIV), director dealing (DIRS), or capital change (SHA/POS) in the sense of issuance/repurchase, but a statement of the current count. It is a specific regulatory disclosure. I will classify it as MRQ as it pertains directly to the calculation basis for major shareholdings, or RNS as a general regulatory filing. Given the French context and the specific article cited (L.233-8 II), this is a mandatory periodic disclosure of the total capital base. I will select RNS as the most appropriate general regulatory filing category when a more specific one like MRQ (which usually implies a shareholder crossing a threshold) doesn't perfectly match the company reporting its own total count, unless the system treats this as a mandatory capital base disclosure under the MRQ umbrella. RNS is the safest fallback for specific regulatory disclosures not covered elsewhere. However, since it is a formal declaration of the capital base, which is the foundation for MRQ filings, I will lean towards RNS as the general regulatory filing category.
2020-12-07 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Share Issue/Capital Change Classification · 1% confidence The document explicitly states its purpose: to release the 'total number of outstanding shares as well as its voting rights as of November 30, 2020,' citing French regulatory requirements (L. 233-8 II of the French « Code de Commerce » and article 223-16 of the AMF charter). This type of periodic disclosure regarding share capital structure and voting rights is a specific regulatory filing. It is not a full Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). It most closely aligns with a notification regarding share capital changes or a specific regulatory disclosure. Since it details the total number of shares and voting rights, it is a specific type of regulatory update. While 'SHA' (Share Issue/Capital Change) is related, this is a mandatory periodic disclosure of the *current count*, not an announcement of a new issue or buyback. Given the context of mandatory disclosure of shareholding thresholds based on AMF rules, and the lack of a perfect fit among the primary financial reports, it falls under a specific regulatory disclosure. However, the closest fit among the provided options that deals with share counts and ownership thresholds is often captured under Major Shareholding Notification (MRQ) or a general Regulatory Filing (RNS). Since this is a mandatory disclosure of the total share count itself, and not a change in a major shareholder's stake crossing a threshold, it is a specific regulatory filing. In many databases, these periodic share count disclosures are categorized as Regulatory Filings (RNS) if they don't fit a more specific category like SHA (which implies an action). Given the options, RNS is the most appropriate fallback for a specific, non-standard regulatory disclosure.
2020-12-07 English
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it is releasing the 'total number of outstanding shares as well as its voting rights as of October 31, 2020,' pursuant to French regulatory requirements (AMF). This type of periodic disclosure regarding share capital structure and voting rights is a specific regulatory filing. While it is not a standard US SEC filing like 10-K or MRQ, it relates directly to share ownership and voting rights disclosure, which often falls under Major Shareholding Notification (MRQ) or a general Regulatory Filing (RNS). Given the content is a precise count of shares and voting rights, it is most closely aligned with the intent of a Major Shareholding Notification (MRQ) or a specific regulatory disclosure. Since MRQ is defined as 'Notification of changes in significant share ownership levels (crossing thresholds),' and this document provides the absolute total number of shares and voting rights, it fits the theme of share structure reporting. However, because it is a mandatory disclosure of the total share count based on a specific date, and not necessarily a notification of a *change* crossing a threshold, it is a general regulatory announcement. In the context of the provided definitions, it is a specific regulatory disclosure that doesn't fit perfectly into the other categories (like ER, IR, or DIV). It is a mandatory disclosure of share capital structure. If we must choose the closest fit among the options, 'Major Shareholding Notification' (MRQ) deals with share counts, but 'Regulatory Filings' (RNS) is the best fallback for specific, non-standard regulatory disclosures. Given the nature of reporting total shares and voting rights, which is often required alongside major holding changes, MRQ is a strong candidate. However, since this is a routine, periodic statement of the total outstanding shares (not necessarily a notification of a *change* crossing a threshold), RNS (General regulatory announcements and fallback) is the safest classification for this specific type of mandatory French disclosure.
2020-11-06 English
Informations privilégiées / Autres communiqués
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Information relative au nombre d'actions et de droits de vote en date du 31 octobre 2020" and explicitly states it is published in compliance with the French Commercial Code (Code de Commerce) and AMF regulations (Article 223-16). It provides a table detailing the total number of shares and the corresponding gross and net voting rights as of a specific date (October 31, 2020). This type of mandatory disclosure regarding the total share capital and voting rights is a specific regulatory filing requirement, often related to major shareholding notifications or general capital structure updates, but most closely aligns with notifications concerning changes in the capital base or significant ownership thresholds. Since it is a formal, periodic disclosure of share capital structure mandated by a regulator (AMF), it fits best under the category for notifications related to significant share ownership changes or capital structure updates. Given the options, 'Major Shareholding Notification' (MRQ) is the closest fit for a mandatory disclosure detailing the total number of shares and voting rights, as these figures are crucial for calculating ownership thresholds. It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI). It is a specific regulatory disclosure.
2020-11-06 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.